Advertisement

Related Videos

Opportunities to Optimize Cancer Policies Panel Discussion

Peter Clark, MA, MD, FRCP: A Payer Perspective

CS Pramesh, MS, FRCS, on Opportunities in India: A Perspective From a Low-Middle Income Country

Javid J. Moslehi, MD, on Cardiovascular and Thrombotic Considerations of Kinase Inhibitors: The Case of BTK Inhibitors

Matthew Seymour, MD: A Clinical Trialist’s Perspective

Advertisement

Advertisement




Nov
06
Today In Oncology
American Lung Association and Prevent Cancer Foundation Host Virtual QIW Workshop: Advancing Routine Clinical Use of Health Information From Chest CT Screening for Public Health
Ponatinib/Blinatumomab Improves Event-Free Survival in Ph-Positive ALL
Izalontamab Brengitecan Improves Progression-Free Survival in EGFR-Mutated Advanced Nonsquamous NSCLC
Anthony El-Khoueiry Named Director of the USC Norris Comprehensive Cancer Center
FDA Grants Accelerated Approval to Amivantamab and Hyaluronidase for Previously Treated HNSCC
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo